Advancements in Gene Therapy, Synthetic Biology, Diagnostic Assays, Imaging Tracers, and Biopharma, 2019 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 30, 2019--The “Advancements in Gene Therapy, Synthetic Biology, Diagnostic Assays, Imaging Tracers, and Biopharma” report has been added to ResearchAndMarkets.com’s offering.
The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) provides recent advances across bioCDMO, synthetic biology, diagnostics and biopharma landscapes.
The TOE provides analytical insights across Cyrus Bench, On/Off Synbio Switches, On-Point Solutions, Extremozymes, IQVIA Core, Homologus recombination, biopharmaceutical manufacturing, diagnostics, imaging, and cell therapy platforms.
Key Topics Covered:Exploring the Potential of Novel Platforms in Life Sciences Cloud-based Molecular Modeling and Protein Design On/Off Switches for Genetically Modified Organisms On-Point Solutions for a Smart Lab Extremozymes for Therapeutics Development Leveraging Human Data Science and Advanced Analytics for Clinical Genomics Leveraging Homologous Recombination for Gene Editing Advancing the Manufacture of Viral Vectors Accelerating the Development of Biopharmaceutical Products Promising Preclinical Data for off-the-shelf Cell Therapy Tau PET Imaging Tracer, APN-1607 Licensed for Use in Tauopathy Clinical Studies Prognostic and Diagnostic Cancer Screening Assays Encouraging Interim Clinical Results of GoCAR-T Cell Therapy Candidate Industry Relations Regional Practice Leaders and Innovation Experts
For more information about this report visit https://www.researchandmarkets.com/research/l5sxxb/advancements_in?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190130005308/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Biotechnology,Genomics,Medical Imaging,Biopharmaceuticals
INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/30/2019 05:38 AM/DISC: 01/30/2019 05:38 AM